Sickle Cell Care Expansion Act of 2023

The Sickle Cell Care Expansion Act of 2023 (S 1423) aims to improve sickle cell disease care through three key provisions. It provides $150 million annually for scholarships and loan repayments to medical students and residents who commit to specializing in sickle cell disease treatment (including 1 year of service per year of funding), prioritizing those from disadvantaged backgrounds. It allocates $50 million yearly for community-based grants to organizations improving health literacy, access to services, and advocacy for sickle cell patients and families. Additionally, it authorizes $70 million annually to fund transition programs helping young adults (ages 18-29) move from pediatric to adult care, including dedicated coordinators and mental health support. The bill directly affects medical professionals, community health organizations, and sickle cell patients, particularly in underserved communities.